148 related articles for article (PubMed ID: 23359302)
1. Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nakajima Y; Kuwabara H; Hattori Y; Ohshima R; Sakai R; Kitagawa M; Tomita N; Ishigatsubo Y; Fujisawa S
Int J Hematol; 2013 Mar; 97(3):427-9. PubMed ID: 23359302
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lim SN; Joo YD; Lee KH; Kim DY; Lee JH; Lee JH; Chi HS; Yun SC; Lee WS; Lee SM; Park S; Kim I; Sohn SK; Moon JH; Ryoo HM; Bae SH; Hyun MS; Kim MK; Kim HJ; Yang DH; Eom HS; Lee GW; Jung CW; Won JH; Kim H; Lee JH; Shin HJ; Jang DY
Am J Hematol; 2015 Nov; 90(11):1013-20. PubMed ID: 26228525
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
Campana D; Pui CH
Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
[No Abstract] [Full Text] [Related]
4. Acute leukemia in pregnancy with ovarian metastasis: a case report and review of the literature.
Terek MC; Ozkinay E; Zekioglu O; Erhan Y; Cagirgan S; Pehlivan M; Mgoyi L
Int J Gynecol Cancer; 2003; 13(6):904-8. PubMed ID: 14675333
[TBL] [Abstract][Full Text] [Related]
5. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Daver N; Thomas D; Ravandi F; Cortes J; Garris R; Jabbour E; Garcia-Manero G; Borthakur G; Kadia T; Rytting M; Konopleva M; Kantarjian H; O'Brien S
Haematologica; 2015 May; 100(5):653-61. PubMed ID: 25682595
[TBL] [Abstract][Full Text] [Related]
6. Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.
Ohyashiki K; Ohyashiki JH; Toyama K
Leuk Lymphoma; 1993 Jan; 9(1-2):43-8. PubMed ID: 8477200
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
Kim SY; Park JH; Yoon SY; Cho YH; Lee MH
Cancer Chemother Pharmacol; 2018 Feb; 81(2):393-398. PubMed ID: 29294168
[TBL] [Abstract][Full Text] [Related]
8. Relapse of acute lymphoblastic leukemia during pregnancy.
Camera A; Campanile M; Catalano D; Mattace Raso A; Rotoli B
Eur J Gynaecol Oncol; 1996; 17(4):303-5. PubMed ID: 8856312
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy.
Mainor CB; Duffy AP; Atkins KL; Kimball AS; Baer MR
J Oncol Pharm Pract; 2016 Apr; 22(2):374-7. PubMed ID: 25616656
[TBL] [Abstract][Full Text] [Related]
10. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
11. AML1 amplification in a child with acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Bastida P; Ortega JJ; Caballín MR
Cancer Genet Cytogenet; 2003 Jan; 140(1):58-61. PubMed ID: 12550760
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM
Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N
Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068
[No Abstract] [Full Text] [Related]
15. [Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia].
Mendeleev IM; Kovrigina TI; Polezhaev IuN
Gematol Transfuziol; 1991 Jan; 36(1):23-5. PubMed ID: 2065941
[TBL] [Abstract][Full Text] [Related]
16. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
[TBL] [Abstract][Full Text] [Related]
17. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
Jabbour E; Kantarjian H; Ravandi F; Thomas D; Huang X; Faderl S; Pemmaraju N; Daver N; Garcia-Manero G; Sasaki K; Cortes J; Garris R; Yin CC; Khoury JD; Jorgensen J; Estrov Z; Bohannan Z; Konopleva M; Kadia T; Jain N; DiNardo C; Wierda W; Jeanis V; O'Brien S
Lancet Oncol; 2015 Nov; 16(15):1547-1555. PubMed ID: 26432046
[TBL] [Abstract][Full Text] [Related]
18. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
19. 10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.
Fujimaki K; Hattori Y; Nakajima H
Int J Hematol; 2018 Jun; 107(6):709-711. PubMed ID: 29188580
[TBL] [Abstract][Full Text] [Related]
20. Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia.
Ramos-Peñafiel C; Olarte-Carrillo I; Maldonado RC; de la Cruz Rosas A; Collazo-Jaloma J; Martínez-Tovar A
Ann Hematol; 2020 Nov; 99(11):2629-2637. PubMed ID: 32980890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
